| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 07/31/2008 | US20080181851 Photoacoustic contrast agents for molecular imaging |
| 07/31/2008 | US20080181850 detecting the presence or absence of expression neuroligin messenger RNA or polypeptides in tumor tissues or blood of humans suspected of having prostate cancer; screening for antisense agents or drugs; medical diagnosis |
| 07/31/2008 | US20080181849 Methods, kits and compositions comprising crotamine |
| 07/31/2008 | US20080181847 kit of imaging probe, e.g.substituted triphenyl phosphine-paramagnetic metal(tetraazacyclododecane) complex; and targeting probe comprises the at least one azide group |
| 07/31/2008 | DE202007008722U1 Farbpaste mit Markierungen in der Röntgen- und Strahlentherapie Color paste with marks in the X-ray and radiation therapy |
| 07/31/2008 | DE102007004283A1 Magnetic resonance contrast agent comprises a polypeptide that binds to a biological structure in the body of a mammal and comprises an amino acid sequence of a bacterial iron-binding protein |
| 07/31/2008 | DE102007002726A1 Neue Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel New cascade polymer complexes, process for their preparation and pharmaceutical compositions containing them |
| 07/31/2008 | CA2676413A1 Diagnostic and therapeutic cyclooxygenase-2 binding ligands |
| 07/31/2008 | CA2674957A1 Nanoparticle-based imaging agents for x-ray/computed tomography and methods for making same |
| 07/30/2008 | EP1949103A2 Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| 07/30/2008 | EP1503803B1 Injectable pharmaceutical composition comprising ethanol for treating herniated invertebral discs |
| 07/30/2008 | CN101233117A Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 07/30/2008 | CN101232905A Oral preparation useful in measuring capacity to metabolize pyridine |
| 07/30/2008 | CN101230331A Use of baicalin in promoting vitro directional differentiation of mesenchymal stem cells and method thereof |
| 07/30/2008 | CN101229382A Novel type radiographic contrast suitable for multi-imaging pattern |
| 07/30/2008 | CN101229050A Method of marking internal lesions position and marking agent |
| 07/29/2008 | US7405342 Transgenic mice expressing heterologous complement receptor type 1 (CR1) molecules on erythrocytes and uses therefor |
| 07/29/2008 | CA2383600C Method for determining viability of a myocardial segment |
| 07/29/2008 | CA2305597C Affinity markers for human serum albumin |
| 07/29/2008 | CA2291685C Pharmaceutical product for the detection of helicobacter pylori-induced gastrointestinal disorder |
| 07/29/2008 | CA2250141C Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen |
| 07/29/2008 | CA2183471C Method and device for the provocation of air passage narrowing and/or the induction of sputum |
| 07/29/2008 | CA2110490C Drug delivery systems comprising gas-filled liposomes at least 90% devoid of liquid in their interior |
| 07/24/2008 | WO2008089281A2 Methods of treating diabetes |
| 07/24/2008 | WO2008089248A2 Amphiphilic substances and triggered liberation from lipid vesicles |
| 07/24/2008 | WO2008088865A2 Antisense and pretargeting optical imaging |
| 07/24/2008 | WO2008088816A1 Adenosine derivative formulations for medical imaging |
| 07/24/2008 | WO2008088648A2 Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules |
| 07/24/2008 | WO2008088561A1 Device and method for labeling and measuring the radiochemical purity of radio-drugs |
| 07/24/2008 | WO2008088524A2 Thrombospondin-domain-deficient r-spondin 1 protein as gastrointestinal tract epithelial proliferation factor |
| 07/24/2008 | WO2008087445A2 Magnetic resonance imaging |
| 07/24/2008 | WO2008087017A2 Novel cascade polymer complexes, method for their production and pharmaceutical agents containing the same |
| 07/24/2008 | US20080177032 Catalytically active peptides |
| 07/24/2008 | US20080175839 Compositions Against Cancer Antigen LIV-1 and Uses Thereof |
| 07/24/2008 | US20080175792 Emulsion; nanoparticles of liquid perfluorocarbon cores coated with lipid/surfactant coupled to integrin specific ligand; 3-({7-[(imidazol-2-ylamino)methyl]-1-methyl-4-oxo(3-hydroquinolyl)}carbonylamino)propanoic Acid adduct with Distearoyl-Glycero-3-Phosphoethanolamine-(PEG)-Maleimide deriv; nonantibody |
| 07/24/2008 | US20080175791 Antitumor agents; immunosuppression; kits |
| 07/24/2008 | US20080175790 Non-invasive; spectroscopy |
| 07/24/2008 | US20080175789 Prostate specific membrane antigen (PSMA); for diagnosis, detection and treatment of cancer; gene overexpression; kits |
| 07/24/2008 | US20080175788 Analyzing for changes in levels of cancer specific genes (CSG) in cells, tissues or bodily fluids compared with levels of CSG in preferably the same cells, tissues, or bodily fluid type of a normal human control: administering antibodies conjugated to cytotoxic agents, which specifically bind CSG |
| 07/24/2008 | DE102007027201A1 Conjugates useful for chemotherapy or positron emission tomography comprising a platinum complex and a glucose compound |
| 07/24/2008 | DE102007004424A1 Eisenoxid-bindende Peptide Iron oxide-binding peptides |
| 07/24/2008 | CA2676313A1 Novel cascade polymer complexes, processes for their preparation and pharmaceutical compositions comprising them |
| 07/24/2008 | CA2675372A1 Magnetic resonance imaging |
| 07/24/2008 | CA2675202A1 Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules |
| 07/23/2008 | EP1945271A2 Polymer coated microparticles |
| 07/23/2008 | EP1945192A2 Nanoscale particles used as contrasting agents in magnetic resonance imaging |
| 07/23/2008 | EP1945159A2 Magnetic nanoscale particle compositions, and therapeutic methods related thereto |
| 07/23/2008 | EP1573314B1 Transgenic mice expressing human cd20 |
| 07/23/2008 | EP1469733A4 Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells |
| 07/23/2008 | EP1123383B1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 07/23/2008 | CN101227921A Use of EphA4 and modulator of EphA4 for diagnosis, treatment and prevention of cancer |
| 07/23/2008 | CN101227897A Applicator and electrostatic patch for screening allergen |
| 07/23/2008 | CN101226199A Effect of N-methyl-D-asparagic acid acceptor in epilepsy generation |
| 07/23/2008 | CN100405511C Water-base magnetic liquid and producing method thereof |
| 07/23/2008 | CN100404585C Polyoxyethylene kind block polymer ligand and synthesizing process thereof |
| 07/22/2008 | US7402728 Transgenic mice expressing human CD20 and/or CD16 |
| 07/22/2008 | US7402727 Model produced by injecting an immunodeficient mouse with a suspension of single cells of human small cell lung carcinoma SBC-5 cells to effect metastasis in the mouse's own bone; used for screening anticancer drugs |
| 07/22/2008 | US7402405 Obtaining sample of blood from mammal; administering digestible first fatty acid- containing substrate; obtaining sample; assaying; determining from the rate of fatty acid absorption of fatty acid-substrate; comparing |
| 07/22/2008 | US7402395 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 07/22/2008 | US7402388 Using immunophilin (FKBP54) expression as diagnostic/prognostic indicator of cell proliferative disorders; antitumor agents |
| 07/22/2008 | US7402299 Intracorporeal medicaments for photodynamic treatment of disease |
| 07/22/2008 | CA2366922C Formulations for detecting asthma |
| 07/22/2008 | CA2283566C Method of measuring physiological function |
| 07/22/2008 | CA2244205C Methods and compositions for enhancing the bioadhesive properties of polymers |
| 07/22/2008 | CA2222544C Site specific binding system, imaging compositions and methods |
| 07/22/2008 | CA2173324C Hybridoma and anti-kc-4 humanized monoclonal antibody, dna and rna encoding it, kit, diagnostic and therapeutic methods |
| 07/17/2008 | WO2008086534A1 Imaging agents and methods of use thereof |
| 07/17/2008 | WO2008085064A2 Hydroxypyridinone chelating agents, their metal complexes and their use as mri contrast agents |
| 07/17/2008 | WO2008084028A2 Coated barium sulphate nanoparticles as contrast agent |
| 07/17/2008 | WO2008061804A3 Marker genes for use in the identification of chondrocyte phenotypic stability and in the screening of factors influencing cartilage production |
| 07/17/2008 | US20080171701 Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury |
| 07/17/2008 | US20080171091 Nanoparticulate compositions of immunosuppressive agents |
| 07/17/2008 | US20080170994 Diagnosis of brain disorders using antibodies capable of crossing the blood-brain barrier and reacting with the pathological substance; Alzheimer's disease, Parkinson's disease, Huntington's disease, bovine spongiform encephalopathy, West Nile virus encephalitis, brain or spinal cord injury, cancer |
| 07/17/2008 | US20080170991 Selectively targeted antimicrobial peptides and the use thereof |
| 07/17/2008 | US20080170990 During vasodilator-induced myocardial stress perfusion imaging, by administering a partial A2A adenosine receptor agonist such as CVT-3033, Regadenoson; diagnosing myocardial dysfunction |
| 07/17/2008 | DE60130743T2 Mikrokugeln zur aktiven embolisierung Microspheres for embolization active |
| 07/16/2008 | EP1944607A2 Toluidine blue O compounds and their manufacture, analysis and use |
| 07/16/2008 | EP1944312A1 Peptides that specifically bind HGF receptor (CMET) and uses thereof |
| 07/16/2008 | EP1944019A2 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 07/16/2008 | EP1942949A1 Method for the synthesis of pentapendant enantiomer-pure chelators and process for therapeutically active bio-conjugates preparation by a covalent binding of thereof |
| 07/16/2008 | EP1942926A2 Stem cell factor-like protein scfa1 and uses thereof |
| 07/16/2008 | EP1942805A2 X-ray system for the creation of diagnostic x-ray images using contrast media |
| 07/16/2008 | EP1163012B1 A kit of parts for use in inhibiting the formation of endoleaks associated with endovascular repair of abdominal aortic aneurysms |
| 07/16/2008 | EP0946712B1 Transgenic animal models with modulated phenotype for alzheimer's disease |
| 07/16/2008 | CN101223148A Perfluoroalkyl-containing complexes, process for their production as well as their use |
| 07/16/2008 | CN101221160A Pulsation circulation type transdermal experiment instrument |
| 07/16/2008 | CN101219225A Improved gastrin releasing peptide compounds |
| 07/16/2008 | CN101219224A Method for preparing microcapsule coated microvesicle ultrasonic contrast medium |
| 07/16/2008 | CN101219223A Medical supersonic couplant with disinfection function and method for preparing the same |
| 07/16/2008 | CN100402092C Gas bearing activator of dry powder in use for diagnosing and/or treating thrombus |
| 07/16/2008 | CN100402020C Medicinal formulation in particular for treating herniated invertebral discs |
| 07/15/2008 | US7399488 Abuse-deterrent pharmaceutical compositions of opiods and other drugs |
| 07/15/2008 | US7399460 Cancer diagnosis; antitumor agents, radiotherapy |
| 07/15/2008 | CA2302524C Stable radioiodine conjugates and methods for their synthesis |
| 07/15/2008 | CA2283327C Cationic lipid compositions targeting angiogenic endothelial cells |
| 07/14/2008 | CA2677686A1 Color-marked oligosaccharides or polysaccharides |
| 07/10/2008 | WO2008081917A1 Spherical ferrite nanoparticle and method for production thereof |
| 07/10/2008 | WO2008081686A1 Cholesterol derivative, liposome, method for forming liposome and contrast agent for x-ray |
| 07/10/2008 | WO2008080195A1 Compositions and methods for treating or preventing unwanted immune responses |
| 07/10/2008 | WO2008063559A3 Methods for using optical agents |